Horizon Health International acquires Samson Industries

HORIZON HEALTH INTERNATIONAL CORP. (Formerly URANIUMCORE COMPANY), OTC-Pinksheet ‘UCCO’, (The Company) on September 30, 2009 concluded the acquisition of Samson Industries Ltd. (Samson) a Canadian Corporation, and approved the issuance of 15 million shares for the acquisition. A voluntary trading restriction for a period of two years is being placed against these shares.

The Company’s Subsidiaries:

The Company’s Business:

The Company through its subsidiaries is expanding its E-Commerce Business throughout North America. The subsidiaries provide services as a ‘Home, Office and Workplace Medical Equipment Specialist’ offering a complete end-to-end shopping experience for Disability Products and Aids for Daily Living through online retail stores across North America.

Our mission. Our mission at Horizon Health International is to help all those challenged by a physical or cognitive limitation or disability to enhance their lives, increase their independence and productivity, and gain greater social inclusion through the use of aids for daily living, disability products, office ergonomics and leading-edge assistive technology.

Our products are used at the office, on construction sites, in homes, as learning aids, in the gym as well as out in the community. Our aim is to build a reputation for excellence in product quality, service, communication and delivery.

Purchasing through our E-Commerce System makes life easier for those challenged by a physical or cognitive limitation or disability. No more trips to a store.

--- SHOP IN THE COMFORT OF YOUR HOME with delivery to your HOME! ---

Continuing the restructuring, the company agreed to settle certain debts registered on its books, and authorized the issuance of a total of 34,706,90 common shares restricted under rule 144 to settle the outstanding debts.

 Soruce: Horizon Health International

Posted in:

Tags: , ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
$1 million grant supports research on groundbreaking therapies for MS